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Abstract
Introduction: Pulmonary amyloidosis is an uncommon disease, characterized by extracellular
deposition of fibrillary protein in the lungs. It appears in three forms: tracheobronchial, nodular
pulmonary, and alveolar septal. There are few reports of long-term observation of primary pulmonary
amyloidosis.
Case presentation: We present the case of a 47-year-old man who presented with fever, dyspnea,
cough and hemoptysis. Chest radiograph and computed tomography revealed multiple pulmonary
nodules and masses. The patient underwent open lung biopsy, which diagnosed pulmonary
amyloidosis.
Conclusion: Pulmonary nodular amyloidosis should be considered in the differential diagnosis of
pulmonary nodules or masses.
Introduction
Amyloidosis is a systemic disease caused by extracellular
accumulation of amyloid [1]. It can be idiopathic (primary
form) or associated with various inflammatory, hereditary,
or neoplastic pathogeneses (secondary or reactive form).
Pulmonary amyloidosis may be part of a widespread
process that involves many organs, or it may be localized
to the airways and lung parenchyma.
Primary pulmonary amyloidosis is a localized form of
amyloidosis that is confined to the lung parenchyma [2-5].
Unlike systemic amyloidosis, localized pulmonary
amyloidosis usually follows a benign course [6]. It can
occur in three forms: diffuse interstitial deposits, single or
multiple pulmonary nodules, or, most commonly, sub-
mucosal tracheobronchial deposits [3-5,7,8]. Although
pulmonary nodular amyloidosis is a rare disease [2], it
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pulmonary nodules or masses, mainly with primary or
metastatic neoplasms and granulomatous diseases [2], and
particularly with pulmonary hyalinizinggranulomas [4,7,9].
Case presentation
A 47-year-old Caucasian man presented with a three-week
history of progressive dyspnea, productive cough, and
weightlossof10kginthepreceding3months. Hesuffered
from several episodes of respiratory infection in preceding
months that improved after antibiotic therapy. He smoked
16 packs per year.
Upon admission, physical examination showed an ill
looking patient who was thin, pale, acyanotic and tachy-
cardic. His blood pressure was 100/70 mmHg, his pulse
100 beats/min, and his respiratory rate was 26 breaths/min.
There was no cervical, axillary, or inguinal lymphadeno-
pathy.Lungauscultationrevealeddiffuselyscatteredcrackles
and rhonchi bilaterally. A physical examination of the heart
and abdomen revealed no abnormal findings.
Laboratory tests showed the following blood analysis results:
redbloodcellcount,4.7milion/mm
3;hemoglobin,11.1g/dL;
hematocrit, 34.8%; white blood cells, 4,300/mm
3;a n d
platelets, 200,000/mm
3. Arterial blood gas analysis while
breathing room air showed an arterial oxygen tension
(PaO2)of80mmHgandanarterialcarbondioxidetension
(PaCO2) of 32 mmHg. Blood analysis further revealed the
following molecular concentrations: sodium, 136 mEq/L;
potassium,4.5mEq/L;bloodureanitrogen,26mg/dL;and
creatinine, 1.1 mg/dl. Liver function tests were normal.
Serology for HIV and tests for acid-fast bacilli and fungi in
three sputum samples were negative. Respiratory function
tests demonstrated a moderate obstructive disease. Echo-
cardiography revealed a normal ejection fraction with no
myocardial or valvular abnormalities.
A chest radiograph (Figure 1) and computed tomography
(CT) on the thorax (Figure 2) showed multiple pulmonary
nodular opacities and masses of soft tissue density that
had irregular contours, and were diffusely and bilaterally
distributed. Most of the nodules and masses contained
calcifications, but none were cavitated. Radiographs
(Figure 3) and CT of the thorax (Figure 4) had been
performed at another institution six years prior, showing
nodular lesions with calcifications that were smaller than
at present. Since he was asymptomatic at the time, he did
not return for further examinations.
Bronchoscopyshowednoabnormalities.Abronchoalveolar
lavage was negative for tuberculosis, fungi or malignancy.
An open lung biopsy was performed and histopathological
analysis showed pulmonary amyloidosis. Three months
later, the patient died from a respiratory infection.
Discussion
Diagnosis of amyloidosis is difficult owing to its diverse
clinical presentation [9]. Amyloid proteins can infiltrate
virtually all organ systems. Pulmonary involvement is most
commonly observed in the localized (primary) form of
amyloidosis [4,7,10]. In this form, males are more affected
than females. The mean age of onset is 55-60 years and
common sites of involvement include the kidneys, lungs,
gastrointestinal tract, and skin [7]. The respiratory system is
involved in approximately 50% of patients diagnosed with
amyloidosis, although radiographic demonstration ismuch
less common [7,8]. As described in detail below, three
patterns of involvement have been described: tracheobron-
chial, diffuse parenchymal, and nodular [3-5,7,8].
Tracheobronchial amyloidosis generally presents with
symptoms of airway obstruction, such as dyspnea or
cough,hemoptysis,andrecurrentpneumonia[9,11].Classic
radiological signs of tracheobronchial disease include
nodular and irregular narrowing of the tracheal lumen,
airway wall thickening, and calcified amyloid deposits.
Lobar or segmental collapse may be seen with endo-
bronchial obstruction from amyloid deposition [4,5,7,9].
Diffuse parenchymal pulmonary amyloidosis is the rarest
form of respiratory amyloidosis [7,9,14]. It usually presents
with dyspnea, cough, hemoptysis, or a combination of
these symptoms. The deposition of amyloid protein causes
alveolar membrane and capillary damage, whichultimately
leads to impaired gas exchange. Radiologically, the diffuse
Figure 1. Chest radiograph demonstrating diffuse pulmonary
opacities with extensive foci of calcification.
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Cases Journal 2009, 2:6540 http://casesjournal.com/casesjournal/article/view/6540Figure 2. Chest CT obtained with lung window settings (A, B and C), revealing nodules and masses, and irregular contours in
both lungs. CT images obtained with mediastinal window settings (C, D and E) show pulmonary lesions permeated by
calcifications.
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appear as nonspecific diffuse interstitial or alveolar opaci-
ties, and, once established, remain stable over time. The
abnormalareascancalcify[14].Ahigh-resolutionCTscanof
the thorax can reveal interlobular septal thickening or
irregular lines that frequently have a predominant basilar
and peripheral distribution [13], as well as small, well-
defined nodules (2-4 mm in diameter), and confluent
consolidations located predominantly in the subpleural
regions.Somenodulesmayshowcalcifications,andsomeof
the areas of consolidation may contain punctate foci of
calcification [2]. When these interstitial findings predomi-
nate, the differential diagnosis includes idiopathic pulmo-
nary fibrosis, scleroderma, and rheumatoid lung disease
[7,13,14].
Nodular parenchymal amyloid deposits usually appear in
multiple sites; focal deposits do occur, albeit much less
commonly. The patients are generally asymptomatic.
Amyloid nodules are generally localized to the lower
lobes, in the peripheral and subpleural areas [12]. They
have four characteristic features on CT: (i) sharp, lobulated
contours; (ii) calcification, often central or in an irregular
pattern within the nodule (seen in about 50% of cases)
[2,4,7,8,12]; (iii) multiple shapes and sizes varying from
0.5 to 15 cm [2,4]; and (iv) slow growth, often over years,
with no regression [4,7,12]. Cavitation is very rare [13].
CT is especially helpful in the demonstration of subtle
calcification, which is often the only finding that can
suggest the diagnosis. Calcification is seen in approximately
half the cases [4,7,12]. The differential diagnosis includes
primary or metastatic neoplasm and granulomatous
diseases [2,4,7,9]. Tissue biopsy is essential for a definitive
diagnosis [9]. Adenopathy occurs predominantly in sys-
temic amyloidosis. This finding may be isolated or more
commonly, associated with parenchymal involvement [13].
The lymph nodes may have calcifications [10,14].
The diagnosis of amyloidosis usually requires histological
confirmation. Histopathological diagnosis is made by
the finding of amyloid, which is an inert, proteinaceous,
homogeneous, acellular, and eosinophilic material that,
when subjected to histochemical staining with Congo red
shows green birefringence under polarized light
[2,4,11-13]. This immunohistochemistry method remains
the gold standard of diagnosis [12].
Management of localized pulmonary amyloidosis is
dependent on the severity of symptoms. Asymptomatic
Figure 3. Posteroanterior (A) and lateral chest radiograph (B), performed six years earlier already showed the presence of
calcified nodules, which were smaller than in recent radiographs.
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Cases Journal 2009, 2:6540 http://casesjournal.com/casesjournal/article/view/6540Figure 4. CT of the thorax performed in the same period as the radiographs in Figure 3, demonstrating scattered pulmonary
nodules, including several with calcifications.
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Cases Journal 2009, 2:6540 http://casesjournal.com/casesjournal/article/view/6540patients may not require treatment [9,12]. Because of the
relative rarity of localized pulmonary amyloidosis, there is
a lack of randomized controlled trials. Various reported
modalities of treatment include bronchoscopic resection,
surgical resection, carbon dioxide laser ablation, and
Nd:YAG laser therapy [12,15]. Parenchymal amyloid
nodules generally grow slowly and remain asymptomatic.
In such cases, treatment is generally not needed. Surgical
resection may be considered; however, there is a possibi-
lity of relapse [9].
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